High-resolution Scatchard analysis shows D1 receptor binding on pyramidal and nonpyramidal neurons

Synapse

Volumn 28, Issue 1, 1998, Pages 83-90

  Davidoff, Stephanie A ^a   Benes, Francine M ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

Atypical antipsychotic; D1 antagonist; Maximal receptor density; Medial prefrontal cortex; Nonpyramidal cells; Pyramidal cells; Receptor affinity

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; RECEPTOR SUBTYPE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIAGNOSTIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; DOPAMINERGIC SYSTEM; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SCATCHARD PLOT; ANIMAL; METABOLISM; RADIOASSAY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; DOPAMINE ANTAGONISTS; MALE; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; TRITIUM;

EID: 9844227355     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199801)28:1<83::AID-SYN10>3.0.CO;2-Z     Document Type: Article

References (38)

1. 3H-SCH 23390 binding in rat striatum. Life Sci., 37:1971-1983.
2. Barton, A.C., Kang, H.C., Rinaudo, M.S., Monsma, F.J., Jr., Stewart-Fram, R.M., Macinko, J.A., Jr., Haugland, R.P., Ariano, M.A., and Sibley, D.R. (1991) Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity. Brain Res., 547:199-207.
3. Benes, F.M., Vincent, S.L., SanGiovanni, J.P. (1989) High resolution imaging of receptor binding in analyzing neuropsychiatric diseases. Biotechniques 7:970-979.
4. 6 receptors in primate brain. J. Neurosci., 18:7821-7836.
5. 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci., 35:1885-1893.
6. 2 subtypes of dopamine receptors in rat brain. J. Neurosci., 6:3177-3188.
7. Claghorn, J., Honigfeld, G., Abuzzahab, F.S., Wang, R., Steinbook, R., Tuason, V., and Klerman, G. (1987) The risks and benefits of clozapine versus chlorpromazine. J. Clin. Psychopharmacol., 7:377.
8. 1 dopamine receptor increase following chronic treatment with SCH23390. Eur. J. Pharmacol., 109:127-128.
9. Dawson, T.M., Gehlert, D.R., McCabe, R.T., Barnett, A., and Wamsley, J.K. (1986) D-1 dopamine receptors in the rat brain: A quantitative autoradiographic analysis. J. Neurosci., 6:2352-2365.
10. 3H]SCH23390 binding sites in human prefrontal cortex (Brodmann's Area 9). J. Neurochem., 49:789-796.
11. 1 antagonist SCH 39166 in six cases of acute psychotic states. Psychopharmacology, 121:323-327.
12. 1-DA receptor antagonist SCH39166 on positive and negative symptoms in schizophrenia. Psychopharmacology, 121:317-322.
13. 2 receptors. Neuroscience 19:125-137.
14. Ellenbroek, B.A., Willemen, A.P.M., and Cools, A.R. (1989) Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in java monkeys. Neuropsychopharmacology, 2:191-199.
15. Emson, P.C., and Koob, G.F. (1978) The origin and distribution of dopamine containing afferents to the rat frontal cortex. Brain Res., 142:249-267.
16. 1 dopaminergic receptor sites in rat striatal tissue. Biochem. Pharmacol., 38:473.
17. Goldman-Rakic, P.S., Lidow, M.S., and Gallager, D.W. (1990) Overlap of dopaminergic, adrenergic, and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci., 10:2125-2138.
18. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41:1.
19. Herkenham, M. (1988) Receptor autoradiography: Optimizing anatomical resolution. In: Receptor Localization Ligand Autoradiography. F.M. Leslie, and C.A. Altar, eds.) Wiley-Liss, New York, pp. 37-38.
20. Huntley, G.W., Morrison, J.H., Prikhozhan, A., and Sealfon, S.C. (1992) Localization of multiple dopamine receptor subtype mRNAs in human and monkey cortex and striatum. Mol. Brain Res., 15:181.
21. Kane, J., Honigfeld, G., Singer, J., Meltzer, H.Y., and the Clozaril Collaborative Study Group (1989) Clozapine for the treatment-resistant schizophrenic. Arch. Gen. Psychiatry, 45:789-796.
22. 1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology, 121:309-316.
23. Kety, S.S., and Matthysse, S. (1989) Prospects for research on schizophrenia. An overview. Neurosci. Res. Bull., 10:456-467.
24. Lidow, M.S., Goldman-Rakic, Rakic, P., and Gallagher, D.W. (1988) Differential quenching and limits of resolution in autoradiograms and brain tissue labelled with 3H, 125I, and 14C-compounds. Brain Res., 459:105-119.
25. Lidow, M.S., Goldman-Rakic, P.S., Gallager, D.W., Geshwind, D.H., and Rakic, P. (1989) Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey. Neuroscience, 32:609-627.
26. Lindvall, O., and Bjorklund, A. (1978) Anatomy of the dopaminergic neuron systems in the rat brain. In: Advances in Biochemical Psychopharmacology. Vol. 19. P.J. Roberts, G.N. Woodruff, and L.I. Iversen, eds. Raven, New York, pp. 1-23.
27. Meltzer, H.W. (1994) An overview of the mechanism of action of clozapine. J. Clin. Psychiatry, 55:47-52.
28. 1 dopamine receptors. Eur. J. Pharmacol., 118:367-270.
29. Richfield, E.K., Penny, J.B., and Young, A.B. (1989) Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience, 30:767-777.
30. 2 receptors in the cerebral cortex of rats, cats, and monkeys. J. Comp. Neurol., 286:409-426.
31. 3H]SCH23390. Brain Res., 375:291-301.
32. Seemen, P. (1993) Receptor Tables, Vol. 2. Drug dissociation constants for neuroreceptors and transporters. SZ Research, Toronto.
33. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant localization in dendritic spines. Proc. Natl. Acad. Sci. USA 91:5720-5724.
34. Thierry, A.M., Tassin, J-P., Blanc, G., and Glowinski, J. (1978) Studies on mesocortical dopamine systems. In: Advances in Biochemical Psychopharmacology, Vol. 19 P.J. Roberts, G.N. Woodruff, and L.I. Iversen, eds. Raven, New York, pp. 205-216.
35. Van Eden, C.G., Hoorneman, E.M.D., Buijs, R.M., Matthijjsen, M.A.H., Gefard, M., and Uylings, H.B.M. (1987) Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopic level. Neuroscience, 22:849-862.
36. 2 receptors in rat medial prefrontal cortex. J. Neurosci., 13:2551-2564.
37. Vincent, S.L., Khan, Y., and Benes, F.M. (1995) Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 19:112-120.
38. Weibel, E.R. (1979) Practical methods for biological morphometry. In: Stereological Methods. Vol. 1. Academic Press, San Diego, 1979, pp. 63-100.